Whole life health insurance by Noronha, Lisete Fernandes de
UNIVERSIDADE NOVA DE LISBOA 
FACULDADE DE CIÊNCIAS E TECNOLOGIA 
Departamento de Matemática 
 
Mestrado em Matemática e Aplicações - Actuariado 
 
 
 
 
 
 
 
 
WHOLE LIFE HEALTH INSURANCE 
 
 
 
 
Lisete Fernandes de Noronha 
 
 
 
 
 
Dissertação apresentada na Faculdade de Ciências e 
Tecnologia da Universidade Nova de Lisboa para obtenção do 
 Grau de mestre em Matemática e Aplicações 
 
 
 
Orientador:         Profª. Doutora Maria de Fátima Varregoso Miguens 
Co – Orientador:  Prof. Doutor Pedro Alexandre da Rosa Corte Real 
 
 
Dezembro / 2008 
  2
ABBREVIATION GLOSSARY 
 
ADSE - Social insurance scheme for public sector workers and civil servants 
CEA – European Committee of Insurers  
CIRS – Código do Imposto sobre os Rendimentos de Pessoas Singulares 
GDP- Gross Domestic Product 
GHD –Global Health Department  
IGIF- Health Financial and Computer Management Agency 
INE – National Statistical Institute  
INSA - National Institute of Health 
NHS – National Health Service 
OECD – Organization for Economic Co-Operation and Development  
PAI - Portuguese Association of Insurers  
PNS – National Health Plan  
SAMS - Health subsystem for employees of the banking sector 
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ABSTRACT 
 
The health insurance has become complementary to the National Health Care 
system in Portugal. In the last years, the increase of this insurance has been 
considerable. Despite the health concerns of Portuguese citizens, related to better 
life quality, medical technology and others, the ageing of Portuguese population is 
a reality to be well thought-out. Regarding this fact, the whole life health 
insurance is an important product to be developed. 
 
In this dissertation, it is presented an approach to the calculation of the level 
premiums for the whole life health insurance in order to fulfil the Portuguese 
insurer’s market requests.  A private health insurance company with a historical 
data of ten years provided the statistics used for this calculation. The levelled 
insurance premiums were calculated on the basis of the risk involved and according 
to the principle of equivalence. This means that regarding the period insured, the 
total of premiums should match the total of the benefits. 
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INTRODUTION 
 
Health is a valuable item, which everyone is concerned about. The Portuguese 
health scheme has three parallel health care systems; one of them is the private 
health insurance.  
The Private health insurance begins its commercialization in Portugal in the year 
1982, and it is a market in truly development. More than twenty two per cent1 of 
the resident Portuguese population over fifteen years old are covered by a health 
insurance. Individuals, families and companies search for the health insurance in 
order to get more quality, efficiency and easy access to the health care provide.  
Concerning the volume of written premiums, the health business presents the 
highest increase, eight per cent (2007/2006)2, far above the other non-life lines of 
business, which reveals the dynamism of this business line. The total health 
spending accounted for ten per cent of the Gross Domestic Product in Portugal in 
the year 2006. 
 
Besides being a market with a rapid growing, many improvements have been done 
in the health insurance, in order to fulfil the insured person’s needs.  
For Health insurers the target question is: How ageing is contributing to immediate 
measures in terms of insurance? The whole life health insurance is a target to 
achieve since the population ageing is a reality nowadays and for the future years. 
 
The main propose of this dissertation is to provide and approach for a method of 
calculation to whole life health insurance level premiums, with Portuguese data 
and risk profiles.  
As population is getting older, the new data available, has allowed sticking 
together the information needed to complete the calculations with a reasonable 
credibility level. 
 
The whole life health insurance (with no limit of age) already exists in some 
European countries. In this study, it will be presented some figures about Germany 
                                                 
1
 Basef Seguros study, Marktest, Junho 2008 
2 Portuguese Association of Insurers, Relatório de Mercado  2007 
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and France health systems, in which countries the whole life health insurances 
subsist. 
 
As an actuary who worked in a health insurance company, the study of this subject 
was motivated due to the fact that is the crucial moment to develop insurances 
with the capacity to cover something as precious as health, with no age limits.  
 
This subject matter is important to Portuguese society because there is gap in this 
segment concerning the age limits imposed by the actual health insurers.  
 
The present study is structured in four chapters. Following the introduction, the 
first chapter presents a global perspective of the Health Care System, with the 
description of Portuguese figures and also an overview of the Germany and French 
health care systems. 
The second chapter is with reference to the whole life health insurance; it 
describes the scope and approach to the data collection that has been carried out 
as part of this study and a suggestion of methodology approach for the level 
premiums calculation.  
The results of the application of the methodology are presented in the third 
chapter and also some sensitivity analysis to the outcomes obtained.  
The last part, presents the conclusions and recommendations that should be kept 
in mind in reviewing this study.  
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1. HEALTH SYSTEM 
1.1 PORTUGUESE HEALTH SYSTEM 
 
1.1.1 HEALTH CARE CONTEXT 
 
The Portuguese Republic Constitution establishes that the right to health 
protection is realised “through a national health service, universal and global, 
which, regarding the economic and social conditions of citizens, is free” [paragraph 
a) of n.º 2 of article 64.º from Portuguese Republic Constitution].  
 
The Portuguese health care system is characterized by three parallel, overlapping 
systems:  
 
I.  The National Health Service (NHS);  
II. Special public and private health insurance programmes associated with 
occupational schemes in accumulation to the NHS (health subsystems);  
III. Private voluntary health insurance schemes. 
 
I. The National Health Service is the major structure that composes the 
Portuguese health system. NHS was created in 1979 with the purpose of 
establishing a nationwide network of public hospitals and health care centers, 
providing primary health care access for all Portuguese population. This 
system covers medical treatment and subsidises an extensive variety of 
medication. 
It is financed mainly through taxation, “for certain health care services 
delivered by NHS facilities the patient pays a certain fixed amount per use. 
For pharmaceutical products, a coinsurance scheme exists, for which the 
patient pays a certain fixed proportion of the cost of the pharmaceutical“ 
(Pita and Simões, 2007). 
  
Actually, in the NHS there are three co-existing management systems:  
 Public administrative management of health synchronized with 
private-public, which is the most common; 
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 Private management and exploration with profit finality of 
equipments and accommodations that have been acquired with public 
funds or medical services paid by the State budget; 
 Economic management of health, which is in strong development. 
 
II. Another structure is the special health insurance programmes associated with 
occupational schemes (health subsystems) in accumulation to the NHS. The 
principal one is the ADSE, a scheme accessible to civil servants and their 
dependents. It covers almost 10% of the population, which corresponds to 1.36 
million enrolled beneficiaries. (Pita and Simões, 2007) 
A further important scheme is the one for Bank workers named SAMS (Union of 
Bank Employees of North, Centre and South Regions and the Islands Medical 
Assistance Services). Many others as the one for military personnel, postal 
workers, insurance company’s employees and Ministry of Justice are also 
special health insurance programmes. 
The advantage of these schemes is that they supply a higher quality, and allow 
to choice health providers.  
 
III.   The last structure is the private health insurance schemes, which have begin in 
1982 , and in 2008, 1,9 million Portuguese persons with age over 15 years are 
insured3. 
The private sector has increased significantly; it is becoming complementary 
to the NHS. 
 
Regarding these schemes, citizens can choose between the NHS and the private 
health insurances or can even enjoy the usufruct of both. In accumulation to both 
of these schemes, part of these citizens is covered by a health subsystem. 
In addition to the health coverage provided by the NHS, approximately twenty five 
per cent of the population is covered by a health subsystem or private health 
insurance.  In particular, around sixteen per cent of the population is covered by a 
health subsystem; approximately twenty two per cent are covered by private 
health insurance and less than two per cent have cumulative coverage from both 
private health insurances and health subsystems. (INSA 2007) 
                                                 
3 Basef Seguros study, Marktest, June 2008 
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In the last recent years the Portuguese public health system has suffered changes 
in order to improve performance. 
As mentioned by Pita and Simões (2007), the measures made since 2002 have 
included: public–private partnerships (PPPs) for new hospitals; a change in NHS 
hospital management rules towards a more entrepreneurial approach and a more 
effective purchaser–provider split; promoting generic substitution of 
pharmaceuticals; liberalization of prices and entry into the Over-The-Counter 
(OTC) market; administrative price reductions for pharmaceutical products; 
introduction of a reference pricing mechanism for pharmaceuticals facing 
competition from generics; regular updates of the co-payments for public health 
care services; reorganization of the public network of services (closure of delivery 
rooms in some hospitals, reshuffling of emergency departments, mergers of 
hospital management teams); definition of a national health plan and creation of 
long-term care networks.  
 
Following the restructuration of the NHS, there has been a conversion process of 
hospitals into enterprises with public money that is still in route. This process leads 
to a new juridical statute and to a hospital management similar to the one of the 
private hospitals. (Banco de Portugal, Relatório anual 2007) 
 
According to the health Secretary of State, mentioned in the parliament (2008), 
the next priority will be the creation of Family Health Units (USFs, Unidades de 
Saúde Familiar). This will extinguish the health sub-regions, in order to complete 
the reform of health primary care with the purpose of getting close to the 
population, giving more resources and autonomy. 
A new network of integrated continuous care is being created between the public, 
social and private sector. 
In the hospital network, there was an improvement regarding the lists for surgery, 
the requalification of maternities and emergencies and also the incentive to 
ambulatory surgery. 
Another current change was the beginning of Saúde 24 as a public center 
responsible for all health telephonic advisers and the widening of operational 
means of INEM (Instituto Nacional de Emergência Médica, IP) 
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Portuguese government is making an effort in order to invest in new hospital 
accommodations and/or make modern some of the existing ones. As mentioned by 
the health Secretary of State (Parliament 2008), the NHS hospitals are getting more 
efficient. He also mentioned that in 2008 the NHS is bigger and better, providing 
more services, more primary care visits or speciality visits. However, the improving 
in the NHS quality and the financing is still a concern. 
 
Between 2004 and 2007, the transfers from State budget to NHS increased only 
2,2%, and for the same period, the GDP raised 10,7%, this means that the relation 
between health expenses and GDP has decreased from 5,2% to 4,8% of GDP. 
 
 
Figure 1.1 - Real Annual Growth Rates in Health Expenditure and GDP, 
2000    to 2006 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: OECD HEALTH DATA 2008, June 08 
 
 
 
According to the OECD Annual Report 2007, healthcare expenditure accounted for 
about 4% of the GDP when the OECD was funded in 1960; but the average across 
OECD countries is now 9%, and it is above 11% in several of the large economies. 
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Figure 1.2 - Health Expenditure as share of GDP, 2006 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
            Source: OECD HEALTH DATA 2008, June 08 
 
 
 
Public expenditure is clearly dominating representing 7.2% of the GDP in Portugal. 
Total health spending in Portugal accounted for 10.2% of GDP in 2006 (OECD Health 
Data 2008 - Version: June 2008), higher than the average of 8.9% across OECD 
countries. 
Health spending per capita in Portugal grew, in real terms, by an average of 3.3% 
per year between 2000 and 2006, below the OECD average of 5% per year (Relatório 
Primavera 2007). Despite spending a high proportion of its GDP on health, Portugal 
spent only 2,120 USD on health per capita in 2006, a lower figure than the OECD 
average of 2,824 USD. 
 
Table 1.1 - Health spending per capita (USD) 
 2000 2001 2002 2003 2004 2005 2006 
Health spending per capita 1509 1569 1657 1824 1913 2029 2120 
Variation 13,5% 4,0% 5,6% 10,1% 4,9% 6,1% 4,5% 
Source: OECD HEALTH DATA 2008, June 08 
 
In Portugal the state contribution in the total health expenditure is lower than the 
average of OECD countries. In percentage terms, the state contribution for each 
Portuguese citizen is 71,9%, lesser than the average of OECD which has a 
percentage of 80,4%. 
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Figure 1.3 – Structure of total Health Expenditure by financing, 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Soure: INE - Conta satélite da Saúde, 2005-2007 
 
 
Public financing is overpowered, in 2006; the NHS was responsible for around 58% 
of the total health expense. The public subsystems financed 7% of total expense. 
The family’s expense was financed around 24% and other private agents like other 
societies, nonprofits institutions at families service, private health subsystems and 
the private health insurances, financed, all together 6%. The expression of Private 
health insurances is still slight with only 2,4% of total expense. 
 
It is well known that health expenses in Portugal, vis-à-vis the produced wealth are 
getting higher. The increase of the health expenses is mostly due to the increase of 
the rhythm of public health expenses. (Pita, 2007a) 
 
 
 
PUBLIC HEALTH MANAGEMENT 
  
The public sector continues to be the main source of health funding in all OECD 
countries, except the United States and Mexico. In Portugal, 71% of health spending 
was funded by public sources in 2006, slightly below the OECD average of 73%.  
According to the Conta Satélite da Saúde em Portugal, Nota Mensal de Conjuntura-
Abril 2006, in Portugal, as occurs in the other OECD countries, there was an 
increase of public health expenditure when comparing to GDP. The European Union 
projections indicate the maintenance of this scenario for the period of 2004-2050 
due to the ageing of population. 
57,5
23,9
7,1 5,7
1,5
1,9
2,4
0%
20%
40%
60%
80%
100%
Private insurance
Private subsystems
Other private
Other Public
Public subsystems
Private family expenditure
NHS
  15
In terms of projection of future public health expenses, the OECD presented the 
following projections to 2050. 
 
Table 1.2 – OECD Projections on Public expenses in GDP percentage 
(%GDP) 
Public expenditure with 
health primary care  
Public expenditure with 
health continuous care  
Total 
2005 2050 2005 2050 2005 2050 
  cost-
pressure 
cost-
containment 
 cost-
pressure 
cost-
containment 
 cost-
pressure 
cost-
containment 
Portugal 6.7 10.9 9.1 0.2 2.2 1.3 6.9 13.1 10.4 
OECD 
average 
5.7 9.6 7.7 1.1 3.3 2.4 6.7 12.8 10.1 
 
Source: OECD, 2006,p31 
 
These projections of public expenses considered two scenarios, cost-pressure 
where containment measures are not considered in public costs, and cost-
containment, where it is considered that governments have made some non 
specified containment. In this last scenario, which is more realistic, it is likely that 
between 2005 and 2050, public expenses with health primary care will increase 
2,4p.p. of Portuguese GDP and 2p.p. in the OECD average. 
OECD expects that the total public health expenses will raise 3,5 p.p. in Portugal. 
If government will implement no containments measures, the financial 
sustainability of health systems would be a problem. 
 
 
According to the Relatório anual 2007 Banco de Portugal, beneath the reform of 
the Portuguese NHS, which began in 2002, there has been a gradual transformation 
of Hospitals into enterprises of public capitals. This change implies a new juridical 
status and a hospital management in close proximity to the private sector. On the 
opposite of the past years, where hospitals received a global transfer from the 
State Budget, nowadays, these enterprise-hospitals have a pre-defined quantity of 
health services hired by year. The financing of these new hospitals is now done 
with a government payment for each medical act. 
In terms of national budget, the enterprise-hospitals are no longer part of the 
public administration sector being part of the institutional sector of non-financial 
enterprises. 
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Table 1.3 – Public administration expenses related to Enterprises-Hospitals 
 
2002 2003 2004 2005 2006 2007 
Amount included in the public 
administration expenses concerning 
enterprises-hospitals 
2.1 0.9 0.9 0.9 0.5 0.1 
Expenses with employees 1.2 0.5 0.5 0.5 0.3 0.1 
Intermediate Consumption 0.8 0.4 0.4 0.4 0.2 0.0 
Payments to the services of enterprises –
hospitals between 2002 and 2007 
- 1.1 1.0 1.1 1.4 1.8 
 
Source: Calculations from Bank of Portugal 
 
 
Table 1.3 illustrates the expenses related to enterprise-hospitals in the perspective 
of the impact in the public administration account. 
In the period of time before the process of “enterprise” (occurred in 2001), the 
expenses associated with the set of enterprise–hospitals between 2002 and 2007, 
which were included in the public administration accounts, achieved around 2.1 
percent of GDP mostly due to expenses with employees. 
 
In the end of 2002, when public administration left the first set of hospitals, it was 
verified an expressive decrease of expenses, around 1.2 p.p. from GDP. 
With the evolution of the “enterprise” process, there was a gradual decrease with 
the GDP ratios in expenses with employees and intermediate consumption. In 2007, 
the process of “enterprise” occurred during the year, as a consequence, the values 
for expenses with employees and intermediate consumption, are not expressive. 
 
Table 1.4 – Public administration expenses in Health (Evolution) 
 20031 20041 20051 20061 20072 
Public Health Expenses (106 euros) 
9.265,7 
 
9.812,6 
 
10.297,5 
 
10.510,4 
 
10.660,6 
 
Public expend. on health as % of 
total expenditure on health 
72,8 
 
71,7 
 
71,4 
 
71,2 
 
69,8 
 
Nominal Variation rate (%) 8,7 5,9 4,9 2,1 1,4 
Variation rate in volume (%) 2,9 1,4 1,3 2,0  
 
1- Definitive, 2- Provisional 
Source: INE, Conta Satélite Saúde 2005-2007 
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Table 1.5 – Public funding for the health system as percentage of GDP 
 2000 2001 2002 2003 2004 
National Health service 61,12 58,80 59,38 59,72 57,57 
Public Subsystems 6,40 6,64 7,69 6,48 7,00 
Other public funding (mainly tax 
benefits) 
4,43 5,19 4,46 5,37 5,73 
Social Security 0,96 0,90 1,00 0,99 0,86 
Total Public Funding 72,91 71,53 72,53 72,58 71,17 
 
 Source: INE, 2006 
 
The Portuguese public expenses in health have a significant share, for instance in 
2006, the total public expenses accounted for 7,2% of GDP. To the future it is likely 
that the expenditure on health as a percentage of GDP will still increase. 
 
Portuguese State makes monetary transfers to NHS, and also has to support other 
health expenses, as the expenses with the health subsystems (ADSE, ect.) 
The NHS expense has benefit from the savings with the conventions and pharmacies 
as a consequence of an improvement in the supply practices, prices reduction and 
medicines reimbursement. These effects were balanced by the payments done to 
the enterprice-hospitals (Relatório anual 2007, Banco de Portugal, Finanças 
Públicas). 
 
The Health care is the second sector to be studied since public spending on health 
amounts to a large share of GDP in most OECD countries, while population ageing 
combined with technological developments are creating strong upward pressures on 
future spending. (Joumard et al., 2008) 
Moreover, Health care plays an important role in explaining health status changes 
over time and cross-country differences. Empirical work suggests that changes in 
health care spending, lifestyle factors (smoking behaviour, alcohol consumption 
and diet), education, pollution and income have been important factors behind 
observed increases in life expectancy and the decline of premature mortality. 
(OECD research into Public spending efficiency) 
 
The most important pressing factors contributing to government expenditure on 
health care are: 
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 Medical technology 
Medical technology might be the most important factor that contributes to 
the expenditure on health. Nevertheless it is directly related to economic 
growth, so that, if the economy increases, there will be provision to invest 
in new technology. On the opposite, if the economic growth is reduced, 
there will be no investment in this area. Medical specialized procedures and 
different diagnosis means in ambulatory will press the health expend, by the 
increase of the frequency and by the raise of the claim cost associated to 
new techniques. 
As concluded by Caldas and Rodrigues (2003), technology and relative prices 
were the main drivers to the increase of spending in health care as 
percentage of GDP. 
According to Health at a Glance (2005), the progresses in medicine capacity 
to prevent, diagnose and treat are the principal factors in the increase of 
health costs. This proposal was also supported in OECD annual report 2007, 
where, once more, the advantages in capacity of medicine to treat and 
prevent health conditions were considered the major factor driving to health 
cost growth.  
 
During the past decade, there has been rapid growth in the availability of 
diagnostic technologies such as computed tomography (CT) scanners and 
magnetic resonance imaging (MRI) units in most OECD countries. Although 
Portugal has also seen some increase in such technologies, the number of 
MRIs in 2006 was 5.8 per million populations, well below the OECD average 
of 10.2. However, the number of CT scanners in Portugal stood at 25.8 per 
million populations in 2006, well above the OECD average of 19.2 per million 
populations. Although the numbers presented to Portugal are above OECD 
average, it is likely that the new technology will continue to develop and 
contribute to the increase of health costs. 
Recent developments in imaging, biotechnology, and pharmacology suggest 
that this trend is likely to continue. 
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 Ageing 
Advances in healthcare and health systems have contributed to 
improvements in longevity and better health, but performance challenges 
still remain.  
The number and share of the population aged 65 years and older have risen 
in all OECD countries since 1960. This trend is expected to continue in future 
decades given the ageing of the baby-boom generation born after World War 
II who will start turning 65 years and older in 2010.  
In 1960 only one out of twelve people was aged 65 and over on average in 
OECD countries. By 2005, this proportion had increased to one out of seven. 
By 2030, more than one person in five is expected to be 65 years and older 
on average in OECD countries, and this share is expected to increase further 
to more than one out of four by 2050 (Lafortune et al., 2007). 
In 2007, the ageing index given by the formula:  (+ 65 years/0-14 years) was 
113,6% (INE, Estimativas Anuais da População Residente). 
 
Figure 1.4 – Portuguese Ageing Index 
 
Source: INE, Demographic Statistics, 2007 
 
 
According to Health at a Glance, 2005, an ageing population trends to need 
higher health care in long-term, as a consequence, it is expected that the 
population ageing will increase public expenses in that area. 
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Figure 1.5 – Public Health Expenditure by age group (% of GDP per capita) 
1) 
 
 
1) Expenditure per capita in each age group divided by GDP per capita 1999; do not include expenditure on long-
term care 
Source: Oliveira Martins and the la Maisonnnneuve (2006) 
 
Public health care expenditure is evidently related with the age of 
individuals. From the sample of countries represented in the figure above, 
Portugal is forth with higher expenditure in the age group 0-4 years, and the 
sixth for ages over 89 years old. 
According to Nixon and Ullman, 2006, life expectancy at older ages provides 
useful information as data available for the public spending component 
suggest that health care expenditure is often concentrated on older age 
groups. 
As mentioned by Caldas and Rodrigues, 2003, while it is true that having 
more elderly around means that society has triumphed in delaying mortality; 
such an event will definitely strain public budgets. Even with people living 
longer, they may not always be in good health, as the risk of becoming 
seriously ill increases with age. On the other hand, even if the future elderly 
are healthy until the end, the unprecedented number of old people coupled 
with the significant costs of treating terminal illnesses are enough to 
warrant our concern about escalating public spending on health. 
 
 
Figure 1.6 – Projection of public health expenses due to population 
ageing between 2004 and 2050 in OECD (%GDP) 
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Source: “The impact of ageing on public expenditure: projections for the EU25 Member States on pensions, health 
care, long term-care, education and unemployment transfers (2004-2050)”, Comissão Europeia, Fevereiro 2006. 
 
The Portuguese projection for 2030 mark a slightly decrease of the public 
expenses due to population ageing, but for 2050 it is expected an increase of 
public health expenses. The amount of Portuguese expenses is close to the 
one of UE15.   
 
Figure 1.7 – Portuguese Life Expectancy from 65 to 69 years (years) 
(a) Estimate calculated by GHD 
Source: PNS 2004-2010, vol.1, pg.56 
Source : INE, Demographic Statistics, 2007 
 
The OECD calculations estimate that in 2040, the life expectancy at 65 will attain 
21,6 years for women and 18,1 years for men. (INE, Nuts- 2002, indicadores 
demográficos) 
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          Table 1.6 – Portugal, Number and Share of the population aged 85 and 
over, 1960 to 2050 
 1960 1980 2000 2005 2030 2050 
Number 35,637 54,487 146,395 143,797 275,378 429,377 
Share 0.4% 0.6% 1.4% 1.4% 2.7% 4.6% 
 
Source: OECD Demographic and Labour Force database (July 2006). 
 
 
As presented in the previous table, it is expected that in 2050, the share of 
population over 85 will achieve 4,6%, which is a really significant value 
considering the expenses related with this age group. 
 
 
 
 Life Expectancy at birth 
 
“If increase in life expectancy comes from a combination of an increase in 
the healthy life expectancy and an increase in time spent requiring long-
term care then there would be an upward pressure on the cost.” (Karlsson et 
al, 2004) 
According to Health at a glance, 2005, life expectancy at birth has increased 
significantly due to better life style quality, better education level, and the 
access to health care and medicine efficiency. As mentioned by Nixon and 
Ullmann, 2006, life expectancy at birth has increased by almost ten years on 
average in OECD countries between 1960 and 2005. 
In Portugal, life expectancy at birth has raised 2,1% between 2001 and 2006 
from 77,1 years to 78,7 years. (Ministério da Saúde - Alto Comissariado da 
Saúde, 2007) 
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Figure 1.8 – Portuguese Life Expectancy at birth (years)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Estimate calculated by GHD 
Source: PNS 2004-2010, vol.1, pg.53 
Source : INE, Demographic Statistics, 2007 
 
As the figure reveal, the life expectancy is increasing along the years and it 
is estimated that in 2010 it will raise up to 81 years old for the Portuguese 
population. 
 
 
 Infant Mortality 
This indicator focuses on the health care system’s capacity to prevent 
deaths at the youngest ages, a period of life where health care spending is 
also relatively high. It has further been argued that infant mortality is more 
relevant for an efficiency analysis than LE itself, since it is less influenced by 
factors not related to the health care system such as education or tobacco 
consumption and infant mortality has been reduced by a factor of seven. 
(Nixon and Ullman, 2006) 
All the OECD countries had considerable improvements considering the 
reduction of infant mortality rates in the past decades. This reduction is due 
to the improvement of global economic and social conditions and also the 
improvements in the health services in the period after birth. Portugal was 
one of the OECD countries with higher infant mortality and is now one of the 
countries with lowest infant mortality. (Health at a Glance, 2005) 
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 Socio-cultural tendency 
Citizens are better informed; the demand level of the actual population is 
growing, as a consequence of the income increase. People search better 
quality and efficiency. The average level of education, allows citizens to be 
more conscientious in relation to health needs and as a consequence the 
increase of the frequency in the health care taking to an increase of the 
health expenditure.  
“Good health status increases with income and education and decreases 
with age and poor health behaviours. We find that income does have a 
significant protective effect for the two oldest groups, 45–64 and 65 and 
over. The results for education are inconsistent.” (KIUILA  et al., 2007)  
 
Education 
Higher education leads to a higher capacity, even with the same level of 
resources (time and health care), to attain a better health status. (Pita, 
2007a) 
According to Nixon and Ullmann (2006), bbetter health is associated with 
higher educational investment, since healthier individuals are able to devote 
more time and energy to learning. Since they live longer, they also have a 
greater incentive to learn because they have a higher return on human 
capital. Moreover, education causes health if better-educated people use 
health care services more effectively, they tend to comply better with 
medical treatments, use more recent drugs and better understand discharge 
instructions. Nixon and Ullmann concluded that education contributes 
significantly to health, over and above its impact on lifestyle factors. 
 
 
Level of Income 
When comparing the level of income with education, Nixon and Ullmann 
state the higher correlation of income with the population health status 
across OECD countries than education. Higher GDP per capita affects health 
by facilitating access to many of the goods and services which contribute to 
improving health and longevity (e.g. food, housing, and transportation. The 
relation between GDP per capita and health may also reflect working 
  25
conditions; richer countries tend to have a higher share of service activities, 
which are considered to be less health damaging than others such as 
construction or industrial activities. The regression results are consistent 
with per capita income being a major determinant of the population health 
status. These results are not altered when replacing per capita income by 
the share of service employment to address causality issues (between per 
capita income and health spending) and to account for the fact that higher 
GDP acts on health mainly via better working conditions in the larger service 
sector. 
 
 
 
 Pharmaceutical 
 
The rise in pharmaceutical spending has been one of the factors behind the 
increase in total health spending in many OECD countries due to the rapid 
increase of medicines expenses in the last years, more than 5% of annual 
increase on average since 1997. In the majority of OECD countries, the 
increase in pharmaceutical expenses has passed the increase verified in the 
total health expenses.  
In 2006, spending on pharmaceuticals accounted for 21.3% of total health 
spending in Portugal, above the OECD average of 17.6%. In 2008, the state 
expenses with products sold in pharmacies has raised 4,2% until July, this 
amount represents eighteen percent of the NHS expenses, according to 
General Direction of the budget. 
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PRIVATE HEALTH MANAGEMENT 
 
The private financing of health expenses has several contributors like the private 
social insurances, private health subsystems, other privates insurances, private 
family expense, nonprofits institutions and other corporations.  
 
Table 1.7 – Private administration expenses in Health (Evolution) 
 20031 20041 20051 20061 20072 
Private Health Expenses (106 euros) 9.265,7 9.812,6 10.297,5 10.510,4 10.660,6 
Private expend. on health as % of 
total expenditure on health 
27,2 28,3 28,6 28,8 30,2 
Nominal Variation rate (%) 7,4 11,7 6,5 3,0 8,7 
Variation rate in volume (%) 1,8 6,5 3,7 0,5  
 
1- Definitive, 2- Provisional 
Source: INE, Conta Satélite Saúde 2005-2007 
 
According to INE, Conta Satélite Saúde 2005-2006, the largest part of the private 
financing is the private family expense with 80% of the total. The private health 
insurance, represent 8% of the private financing, and it is likely that this proportion 
will continue to be considerable as the health insurance market is developing, in a 
way that provides multiple choices regarding coverages and premiums. 
 
Table 1.8 – Private funding for the health system as percentage of GDP 
 2000 2001 2002 2003 2004 
Private subsystems 1,72 1,79 1,88 2,35 2,24 
Voluntary Health Insurance 1,44 1,42 1,82 2,24 2,47 
Out-of-pocket payments 23,19 23,15 23,15 21,16 23,56 
Other private funding 0,74 2,10 0,12 1,68 0,77 
Total Private Funding 27,09 28,47 27,47 27,44 28,83 
 Source: INE, 2006  
 
Regarding the data available, the percentage of the total private funding has been 
quite stable. The main contribution for the private funding is from Out-of-pocket 
payments, which represent 82% of this item. 
 
The average of Family’s health consume in terms of percentage of GDP is 2,8%.  
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The conclusion of the Relatório de Privavera, 2008, points out to a better quality 
of the private health services, due to the financing, almost in totality, by the 
state. As mentioned in that report, the health private system is still feasible if it 
will continue to be financed by government.   
Public health and private sector are changing significantly. Private offer is now 
abundant, generally with better quality and in some cases with high technology. 
(Relatório de Primavera, 2008) 
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1.1.2 PRIVATE HEALTH INSURANCE  
 
 
The general definition of the health insurance describes it as a form of insurance 
that pays for medical expenses. Sometimes it is used more broadly to include 
insurance covering disability or  long term nursing custodial care needs. It may be 
provided through a government-sponsored social insurance program, or from 
private insurance companies. The health insurance may be purchased on a group 
basis (e.g., by a firm to cover its employees) or purchased by individual consumers. 
In each case, the covered groups or individuals pay premiums or taxes to help 
protect themselves from high or unexpected healthcare expenses. Similar benefits 
paying for medical expenses may also be provided through social welfare programs 
funded by the government. By estimating the overall risk of healthcare expenses 
and developing a routine finance structure (such as a monthly premium or annual 
tax) that will ensure that money is available to pay for the healthcare benefits 
specified in the insurance agreement. The benefit is administered by a central 
organization, most often either a government agency or a private or not-for-profit 
entity operating a health plan.  
 
In the Portuguese case, the health insurance is provided only by private insurance 
companies and it is cumulative to the public service and the participation in these 
schemes is voluntary. 
The Portuguese supervisor entity is named Portuguese Association of Insurers (PAI), 
it was funded in 1982 and is a nonprofit entity, which joins the insurance 
companies and reinsurances that operate in the Portuguese market besides their 
nationality. The group of insurers that belong to PAI represent more than 99% of 
the insurance market regarding the business volume and total employees.  
PAI is the entity that represents the insurance sector, the principal objectives of 
are: 
 Represent and defend the interests of their associates in a national and 
international level; 
 Promote the cooperation between the associates and defend their common 
positions; 
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 Contribute to the modernization, the prestige and the development of the 
sector; 
 Give support to their associates, particularly trough the realization of 
technical studies; 
 Organize and manage services that are common interest for the companies 
of the sector; 
 Support any other actions that are an interest for insurance companies- 
 
 
Private health insurance represents, on average, only a small share of total health 
funding across the OECD area. These insurances play a significant role in health 
financing in some OECD countries and it covers at least 30% of the population in a 
third of the OECD members. (Colombo and Tapay, 2004) 
 
In Portugal, in the year 2007, about 1,7 million persons were insured4. According to 
Basef Seguros study from Marktest, June 2008, 1,9 million Portuguese citizens with 
age over 15 years old have a health insurance. 
 
As mentioned by Colombo and Tapay, 2004, the private health insurance is a 
complex financing mechanism that affects and interacts with public systems in 
multiple ways. Some have argued that the private sector has the ability to find 
more responsive and efficient answers to policy challenges facing health systems, 
and would enable governments to cut public health sector costs. As a result, 
supporters see private health insurances markets as more dynamic, innovative, and 
sensitive to individual preferences and consumer demands than public systems, 
which are conversely plagued by bureaucratic slowness and rigidities. Private 
health insurers also often offer a considerable array of products to their consumers 
and therefore have the potential to promote choice of benefits and financial 
protection schemes and better meet individual preferences.  
 
 
 
 
 
                                                 
4 PAI, APSBreve #57, 16 June 2008 
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1.1.2.1 CHARACTERISTICS  
 
The health insurance is a private contract between the insurance company and the 
policyholder, which sets the level of an insurance premium in exchange for a set of 
coverages in the health care domain. Against the payment of the premium, the 
insurance company has the duty, in the case that any risk event occurs that is 
covered by the insurance, to reimburse the insured person by their spends, or 
satisfy the provision for the medical and health care which are necessary to the 
recovery of the patient through the financing of the providers. 
 
As mentioned by Pita and Simões (2007), the majority of health insurances policies 
in Portugal are valid for only one year and consequently companies have the power 
to cancel and/or refuse to renew the contract. In addition, policies tend to be 
selective and lack comprehensiveness: as age is strongly associated with increased 
health care costs, many companies will try to exclude anyone over 65 or 70 years 
old. However this is a tendency that is changing and it is becoming usual to get 
health insurances without age limits. 
 
Some definitions of the health insurance terms: 
 The policyholder is the person who hires the insurance and the responsible 
for the payment of the premiums.  
 The insured person is the one who holds the insurance, whose health or 
physical integrity is insured, and who is entitled to benefit under the policy. 
 
The health insurance contract is composed by the insurance proposal, the 
individual medical questionnaire and medical documentation necessary for the 
acceptance of the risk from the insurance. 
 The insurance proposal is a formulary of the insurance company that has to 
be filled in by the policyholder or by each candidate. The content of this 
document has enough information to accept or refuse the insurance 
contract.   
 The measure of the medical risk is essential; therefore the insurance 
company makes an individual medical questionnaire to all candidates to be 
insured using a patient's medical history to screen out those whose pre-
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existing medical conditions pose too great a risk for the risk pool. In general, 
those who present pre-existance diseases are considered as exclusion or 
charged high premiums to compensate. 
 This formulary has a set of health indicators in order to constitute a profile 
and a clinic history, which can correctly quantify the risk to be assumed by 
the insurance. Some of the contents of the questionary may be the name of 
the actual medical practioner/ health institution used, the biometric 
indications (height, weight and blood pressure), general questions about 
habits, life style, diseases or disturbs and the personal health history.  
The medical questionnaire is also a mean to avoid what the insurance 
company’s name “adverse selection”, which is the tendency for only those 
who will benefit from insurance to buy it. Unhealthy people are more likely 
to purchase health insurance because they anticipate large medical bills. On 
the other side, people who consider themselves to be reasonably healthy 
may decide that medical insurance is an unnecessary expense. 
 Beside the information of the individual medical questionnaire, regarding 
the age of the person and the guarantees wanted, the insurance company is 
able to request further medical exams to get a good risk evaluation.  
 
The Documents that set out terms and conditions and are part of the health policy 
are: 
 General Conditions, clauses that define and regulate the general terms and 
common responsibilities under the insurance policy. 
 Special Conditions, clauses defining the benefits applicable under the 
general conditions; 
 Specific Conditions, the specific aspects of each insurance policy as 
reflected in the individual supplied to each household; 
 Policy, the contract between the policyholder and the insurance company 
that includes the agreed general, special and specific terms and conditions 
and all policy endorsements. 
 Policy Endorsement, changes made to the terms and conditions of the 
policy. 
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Insured people can benefit from the guarantees of the health contract if they 
satisfy the follow conditions: 
 Satisfy the insurance company acceptance conditions, in function of the risk 
evaluation parameters like the pre-existing diseases, the limit age of 
underwriting; 
 Fill properly the individual medical questionnaire, truthfully and with full 
disclosure; 
 Be accepted by the insurance; 
 Accept the utilization rules of health care. 
 
The admit ion of the insured person will be confirmed by the insurance, but it can 
have some restrictions as the elimination period and exclusions. 
 Elimination period, time between the date of the beginning of the insurance 
or the date of the inclusion (if it is the case of a group policy) and the date 
when the guarantees can be used. For example, the elimination period for 
the childbirth coverage can be around 18 months; 
 Exclusions, there are several pathologies excluded by the health insurances. 
There are also some aggravate risks which became from the possibility of 
need health care due to the professional area, style of life or family history. 
Under these circumstances, the risk can be accepted with limitations. Some 
of the exclusions for aggravate risks are the pre-existing diseases or 
accidents occurred prior to the effective date of the health insurance, 
professional diseases or accidents, mental illnesses, plastic surgery, 
Haemodialysis and others. 
 
Citizens, families and companies can subscribe the health insurance; therefore it 
can be sign up as two modalities: Individual and Group.  
 
In Portugal, more than half of the policies are Group insurance provided by the 
employer, and the others are Individual policies (50.9% in 2004 and 52.2% in 2005 
(INE, 2006)). For 2006, 56% were group polices and 44% individual policies. (PAI, 
Estat_Doença_2006)  
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 The individual policy is underwritten by a singular person and can be extend 
to the dependent family; 
 The group policy is usually hired by a collective person (policyholder), and 
covers a set of people who have an entail or an interest in common.   
The group insurance can be contributively, if the insured people contribute 
total or partially to the payment of premium or non-contributively 
insurance, when the policyholder contributes totally to the payment of the 
premium. 
Companies have being celebrating health insurance contracts to their 
employees as an extra payment and also as their social responsibility. 
 
The health insurance can assume two modalities regarding the system of medical 
claims payment: 
 Reimbursement: in this classic type of insurance, the insured person has the 
responsibility and is free to choose any health provider (hospital entities, 
doctors or medical units). The medical expense is totally supported by the 
insured person who, afterwards, will presente the expense to the insurance 
company to be reimbursed under terms and restrictions for each annual 
period, set out in the specific conditions and after deducting relevant excess 
and co-payments. 
 
 Managed Care: this is a more recent kind of insurance. In this system the 
insured person has the access to a network system of managed healthcare, 
with healthcare providers and prices established in a previous contract. 
Concerning the choose of the healthcare, the insured person can decide by 
two options:  
-Visit a provider that belongs to the network system, being incharged (if 
it is establish that way) for a part of the expense, the co-payment as 
defined in the contract with the insurance company. 
- Visit a provider out of the network. In this case, the contract works like 
the reimbursement modality. As a consequence, the reimbursement 
percentage would be, in the majority of private health insurances, less 
than the one in the network; this is the case of mix insurance. 
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         Table 1.9 - Managed Care/ Reimbursement - Premiums structure 
Percentage 2002 2003 2004 2005 2006 
Reimbursement insurance 41% 31% 26% 21% 27% 
Managed Care insurance 59% 69% 74% 79% 73% 
Source: PAI, Estat_Doença_2006 
 
The evolution of the numbers above shows the increase and the preference 
of the managed care system. This raise is partly due to the net of providers 
in each health insurance company that has increased, which allows a 
significant choise for the insured person with certainly lower costs. 
 
 
         Table 1.10 – Managed Care/ Reimbursement – Insured People 
U: Th ousand  2002 2003 2004 2005 2006 
Reimbursement insurance 268.058 400.316 437.150 415.970 480.828 
Managed Care insurance 678.262 832.959 873.494 985.109 1.136.093 
Source: PAI 
  
As the table of premiums structure expressed, the number of insured 
persons with the managed care option is the majority. 
 
 
COVERAGES / PLAN INSURED 
 
The health insurances companies have almost the same coverages in the market. 
This insurance has more than a few ways to compose the plan of the policy due to 
the arrangement of the different coverages, annual limits and percentage of 
reimbursement. The insured person is free to choose the product wanted from the 
ones available in the insurance company. 
 
The most common coverages are: 
  
Table 1.11 – Health Insurance Coverages 
COVERAGE DESCRIPTION 
IN-PATIENT The benefit is for provision of in-patient health care including outpatient 
care, subject to clinically proven need for such in-patient care. 
Eligible expenditure under in-patient cover is that related to payment for 
medical treatment, surgery or laboratory analyses that require resources 
and specific services that can only be provided and performed as an in-
patient in a hospital environment, namely the following between other: 
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COVERAGE DESCRIPTION 
 Fees related to treatment carried out in the hospital namely for 
doctors/surgeons, anaesthetists, assistants and instrument costs; 
 Supplementary Diagnostic and Therapeutic resources associated with 
the treatment carried out in the hospital environment; 
 Nursing fees related to in-patient treatment; 
 Resources used in in-patient treatment (operating theatres, recovery 
ward, private room or nursing ward); 
 Surgically implanted Prosthetic Devices 
CHILDBIRTH The insurance company undertakes to ensure access for the insured person, 
in terms of and to the limits established under the Specific Conditions, to 
in-network healthcare service providers in terms of natural childbirth, 
caesareans and voluntary interruption of pregnancy except for illegal 
abortion 
OUT-PATIENT Eligible expenditure under in-network healthcare service provider cover is 
that related to payment for medical treatment, surgery or laboratory 
analysis, that does not require to be provided and performed as an in-
patient, namely: 
 Medical visits 
 Medical fees related to out-patient; 
 Supplementary Diagnostic and Therapeutic resources associated with 
out-patient treatment provision; 
 Medicines administered during such treatment period; 
 Materials, equipment and products associated with outpatient 
treatment; 
 Nursing fees related to out-patient treatment; 
 Home nursing care 
 Ambulance or other means of transportation from and to health care 
centres, providing the insured person’s health condition so requires; 
MEDICINES Reimbursable expenses are only paid after the assumptions below are 
verified 
 Medicine should be prescribed by a registered practitioner and be for 
treatment of lesions arising from illness or accident covered by the 
contracted benefit; 
 Depending on the case, the original or copy of the medical 
prescription, countersigned by the supplying pharmacy and to include 
package price tag and/or barcode, or prescribed medicine registration 
number and corresponding receipt should be sent to the insurance 
company. The claim should clearly and legibly set out the medicines 
supplied and the amounts, following deduction of reimbursable amount 
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COVERAGE DESCRIPTION 
where these apply, paid by the insured person 
DENTAL Reimbursable expenditure under policy cover for healthcare providers 
within the approved network relate to: 
 Visits 
 Dentistry (restoration and filling of cavities) 
 Periodontology (removal of tartar) 
 Minor Oral Surgery 
 Prosthetic Devices 
 Orthoses (corrective apparatus) 
 Supplementary Diagnostic Methods 
PROSTHETIC 
DEVICES/ 
ORTHOSES 
 
 Prosthetic Devices 
All clinically conceived and/or recommended instruments designed to 
replace, totally or partially, a member of or organ in the body. 
 Orthoses 
All clinically conceived and/or recommended instruments designed to 
help, totally or partially, the functioning of a member of or organ in 
the body. 
 
 
 
 
 
 
  
FISCAL BENEFITS 
 
The Portuguese government had established fiscal benefits that contribute as an 
incentive to invest in health insurances. 
According to the article 86º from CIRS, the amounts spend in the health insurance 
premiums; allow a deduction to the collective income of 30% for individual and 15% 
of the total expenses related to salaries to group policies. 
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1.1.2.2 HEALTH INSURANCE PREMIUM CALCULATION 
  
In the Portuguese health insurance market, there are three different groups to be 
rated. 
 
The Individuals, the Small Groups, which are enterprises with less than fifty 
employees and the Large Groups with more than fifty employees. 
 
Usually for the Individuals and Small Groups, the insurance market has standard 
polices.   For the Large Groups, the rating options are the various; there are 
several methods that an insurance company may use to determine the premiums to 
charge a small group for health insurance.  
 
For the Individuals, premiums will generally vary by age and gender but not with 
health conditions. 
 
Premium rates in the Small Groups market are generally subject to rating band 
limitations, determined on case characteristics, consisting of age and gender of 
employees, location, number of employees and type of insurance product. 
The most common rating method for small group health insurance is age banded 
rating. With this method, the insurance company provides a different rate for each 
employee, based on the age of that employee. Typically, the older the employee, 
the higher the premium that will be charged for that employee’s portion of the 
group health plan. The insurance company sets these age-banded rates by looking 
at claims history for persons under other group health plans that are of similar age. 
Rates usually increase with age because claims also increase with age as a person 
develops more health conditions, as they get older. The insurance company may 
look at other factors in determining the age-banded rates, such as the geographic 
location of each employee’s residence and their gender. Some insurance companies 
base rates on the geographic location of the business and not that of the 
employees. 
The Large Groups are rated through two different methods. The methods used by 
insurers to establish health insurance premiums are the Community Rating and the 
Experience Rating. 
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 The community rating is the standard for setting health insurance premiums, 
which eliminates health status, age, gender or claims history. 
Its principle is to average the cost of medical care not only among all 
individuals having the same expectations of loss, but also among others of 
different degrees of risk. Both low-risk and high-risk classes are factored 
into community rating, which spreads evenly the expected medical care 
costs across the entire community 
With community rating method, for a given level of cover, everyone pays the 
same. Pure community rating is rarely used; it is uncommon because it is a 
good deal for older people, who would otherwise pay higher premiums, but 
not for people who are younger. Most countries do not use pure community 
rating because younger people feel they cannot afford it, and drop out of 
the health plan. When younger people drop out of the group plan, only the 
sick and the elderly remain, which is not a boon for insurance companies. 
“Community rating is controversial in the health policy community. Some 
feel that it drives premiums higher, forcing lower-income individuals to go 
uninsured. Others believe that it offers a crucial opportunity for those with 
expensive health problems to obtain affordable coverage.”(Kelly 
Montgomery, About.com) 
 
Modified community rating, however, is a common underwriting method 
under which a managed care organization categorizes its members into 
classes or groups based on some common characteristics as age, gender, 
type of economic activity or demographic factors and then charges all 
members of a class or group the same premium. The plan cannot consider 
the experience of a class, group, or tier in developing premium rates. Also 
known as modified community rating or community rating by class. 
Another rating option is called composite rating. Under a composite rating 
method, the insurance company will calculate one set amount that will be 
charged for each eligible employee enrolled in the group health plan. For 
companies that offer this rating option, they calculate the average premium 
based on the persons enrolling when the group health plan is first 
established. They add the total age banded rates together for all persons 
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enrolling, and then divide that number by the number of employees. 
Composite rating allows for ease of record keeping for the employer and 
equals the amount of contribution he makes per employee, thus providing 
equally valued benefits to each employee. Most insurance companies will 
only allow composite rating if the total number of employees enrolled in the 
group health plan exceeds a minimum number, such as 10. 
 
 A premium rate based on the observed claim rate for a heterogeneous 
portfolio might prove quite inadequate if, as is likely, the mix of risks were 
to change. To reduce this danger, policies are usually grouped according to 
the different levels of the various risk factors involved. Claim frequency 
rates and premiums for the different groups are then calculated. This 
approach to the problem is called group rating. (Hossack et al., 1999) 
Experience rating or risk selection method is a system used by insurers to set 
health premiums based on the insured's past loss experience, which analyzes 
a group's recorded healthcare costs by type  (claims and health care usage), 
and where the risk is distributed equally over all groups according to their 
health status. The group's premium can be partly or completely calculated 
according to the group's experience. 
 
 
The methods described above calculate the pure premium, which is the amount 
that corresponds to the expected claims that the insurer will have to pay. In the 
case of the health insurance, the expected amount of claims is the amount of 
benefits that the insurer will pay in order to provide the medical care assistance 
hired with the policyholder. 
Over the pure premium there are other factors that contribute to the final 
premium to charge to the policyholder. The cost of advertising, selling, paying for 
services rendered by health care practitioners, administration of the insurance 
program as well as the investment of premium payments and a profit margin are 
factored into the premium amount.  
Additional underwriting factors, such as adverse selection for individual policies 
and special industry exposures for employer-sponsored group health insurance 
plans, are also factors of the premium charged. 
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The Policyholder often can control several factors used to determine the insurance 
premium. Some of these factors, which act as limitations of the insurance 
coverage, include: 
 
 Deductibles - The amount the policyholder has to pay out-of-pocket before 
reimbursement of expenses from the insurance coverage. The patient pay 100 
percent of the first portion of their medical costs up to a specified maximum 
before his insurance plan picks up all or part of the remainder of the price of 
the services. 
Depending on the chosen amount, it may take several medical acts before the 
policyholder reaches the deductible amount and the health plan starts to pay 
for care. The higher the deductible, the lower the premium; 
 
 Copayments – The amount that the policy-holder must pay out of pocket for a 
particular medical act each time they use that service. The higher the co-
payment, the lower the premium; 
  
 Coverage limits - A mechanism by which policyholder is reimbursed for a 
medical expense up to a maximum amount of money, or a maximum amount 
of services. In addition, some plans have annual coverage maximums. In these 
cases, the health plan wills stop payment when they reach the benefit 
maximum. Any expenditures above that or services above the limits become 
the responsibility of the policyholder. The higher the coverage limits, the 
higher the premium; 
 
 Out-of-pocket limits - the maximum amount of deductible and co-payments 
that the policyholder has to pay each year. The policyholder payment 
obligation ends when they reach the out-of-pocket maximum, and the health 
plan pays all further covered costs. Out-of-pocket maximums can be limited to 
a specific benefit category (such as prescription drugs) or can apply to all 
coverage provided during a specific benefit year;  
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 Coinsurance - In which the policyholder must pay a percentage of the total 
cost. Because there is no upper limit on coinsurance, the policyholder can end 
up owing very little, or a significant amount, depending on the actual costs of 
the services they obtain. The higher the coinsurance, the lower the premium; 
 
 In- Network Provider – A health care provider on a list of providers preselected 
by the insurer. The insurer will offer discounted coinsurance or copayments, 
or additional benefits, to a plan member to see an in network provider. 
Generally, providers in network are providers who have a contract with the 
insurer to accept rates further discounted from the usual and customary 
charges the insurer pays to out-of-network providers; 
  
 Coordination of Benefits - some insurance companies now offer insurance 
plans which recognize the fact that other insurance may be available to the 
policyholder, such as coverages under worker's compensation, automobile 
insurance, a state disability program, or from coverage available as an 
employee benefit to a spouse. This provision specifies how multiple coverages 
will coordinate their payments; 
 
 Renewability/Cancellation - some insurance companies offer health insurance 
on a guaranteed renewable basis or with a non-cancellation provision 
(meaning that the insurance company may only cancel coverage in the event 
of non-payment of premium). Expect there to be an added cost for these 
features; 
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1.1.3 HEALTH INSURANCE MARKET 
 
Although the basic principle of public health system is “… universal and global, 
which, regarding the economic and social conditions of citizens, is free”; many 
people hire a health insurance. Private sector has been supporting and covering the 
insufficiencies verified in the public sector. Nevertheless, private consumers 
cannot leave SNS, and SNS benefit from their contributions. 
 
According to the OECD research into public spending efficiency, the Public 
satisfaction with the health care system can be a criterion for assessing its 
performance. Satisfaction is, however, affected not only by people’s experiences 
with the health system but also by their expectations, which are likely to vary 
significantly across countries and over time.  
 
The Private health insurance is increasing in many countries. There are several 
reasons associated with this raise as the growing dissatisfaction with public health 
care, the liberalisation of markets and the increased international trade in the 
insurance industry, as well as overall economic growth allowing higher and more 
diversified consumer demand. (Drechsler and Jütting, 2005)  
 
Other reasons for the increasing of the private health insurers are associated with 
the constant medical innovation, the difficulty in accessing the NHS, the increase 
of the offer and the current tax incentives encouraging high earners and 
companies. 
 
The insured person hires a private health insurance in order to fulfil some of the 
public system gaps and expects to get from the insurance more efficiency; quality 
and comfort in the health care assistance domain. With the insurance, there is no 
need to wait; in case of in-patient, there is the possibility of choosing a private 
room with all the comfort required. Another important issue is the free choise 
between a large and broad providers network in professional agreement with the 
insurance company. 
 
The global insurance premiums amount has increased, in the period 1998–2004 at 
an annual average rate just below 20% (INE, 2005).  Between 1995 and 2007, the 
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health insurance market has increased 5.4 times concerning the direct insurance 
premiums, from 102 to 440 million euros (PAI, Relatório Mercado 2007). 
In 2007, the increases of the health segment was almost 8%, which correspond to 
the tendency of the last years. 
 
Table 1.12 – Health Direct Insurance Premiums 
Million € 2002 2003 2004 2005 2006 2007 
Premiums 273 315 346 372 408 440 
Variation 20,0% 15,4% 10,2% 7,2% 9,7% 7,9% 
% of direct premiums 
over GDP 
0,21% 0,23% 0,25% 0,26% 0,27% 0,29% 
Source: PAI, Relatório de Mercado 2007  
 
As the previous table displays, direct premiums have raised every year, some years 
more than others. The variation for 2007 is 7,9% below the previous year with 9,7% 
of increase. 
 
According to Pita and Simões 2007, approximately a quarter of the population 
enjoys a second (or more) layer of health insurance coverage through health 
subsystems and voluntary health insurances. 
 
 
 Table 1.13 – Number of Health insured persons 
U: million 20021 20031 20041 20051 20061 20072 20083 
Number of health insured 
persons  
1.3 1.4 1.4 1.5 1,6 1,7 1,9 
Variation  6,2% 4,3% 4,8% 6,7%   
Source: 1 PAI, CGD; 2PAI, APSbreve, 16 June 2008; 3Marktest, June 2008 
 
The health insurance market presented in the last years a sustained evolution, 
which represents the increasing acceptance of the Portuguese consumers about this 
product. 
The current number of health insured persons is actually around 1.9 million 
consumers. 
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Table 1.14 – Health Gross premiums, Group vs Individual 
Thousands euros 20041 20052 20062 
 
Gross 
Premium 
% 
Gross 
Premium 
% 
Gross 
Premium 
% 
Group 183 170 54% 210 044 56% 218 127 53% 
Individual 156 419 46% 164 385 44% 190 321 47% 
1represents a sample of 97%; 2represents a sample of 99,9% 
Source: PAI, Estatistica do Ramo Doença, 2004, 2005-2006 
 
 
Companies, in favour to their employees, celebrate the major part of insurances, 
but the individual segment has also an important dimension. As the data available 
of PAI presents, according to the amount of gross premium, 53% of premiums 
correspond to Group policies in the year 2006. 
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1.2 GERMANY HEALTH SYSTEM 
 
1.2.1 HEALTH CARE CONTEX 
 
 
According to OECD Health Data 2008, How Does Germany Compare, the health 
spending accounted for 10.6% of GDP in Germany in 2006, more than 1.5 
percentage points higher than the average of 8.9% in OECD countries. 
Only the United States (15.3%), Switzerland (11.3%) and France (11.1%) allocated 
more of their GDP to health than Germany in 2006. 
Moreover, Germany ranks only 10th among OECD countries in health spending per 
capita, with a spending of 3,371 USD per person in 2006 (adjusted for purchasing 
power equality). The OECD average in 2006 was 2,824 USD per capita. 
Health spending per capita in Germany increased, in real terms, by 1.4% per year 
on average between 2000 and 2006. This was the smallest increase among all OECD 
countries during this period. 
The relatively slow growth in health spending in Germany is partly due to cost-
containment measures that have been introduced in the context of health reforms. 
In Germany, 77% of health spending was funded by public sources in 2006, above 
the average of 73% in OECD countries. 
In 2006, life expectancy at birth for the whole population in Germany stood at 79.8 
years, nearly a year more than the OECD average of 78.9 years. 
 
 
As mentioned in Economic survey of Germany 2008: Moving towards more 
sustainable healthcare financing, in the face of considerable spending pressures 
stemming from technological and demographic changes, Germany needs to reform 
healthcare financing to make it efficient and limit the negative impact on 
employment and growth. The predicted gradual increases in budget contributions 
to the social health insurance system will help reduce non-wage labour costs, if and 
when they materialise, as general taxes draw on a larger base than labour-income-
dependent social insurance contributions, which are the main financing source of 
the social health insurance system now.  
The new financing system for the social health insurance system linked to an 
improved risk structure adjustment between insurers could reduce the incentives 
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for risk selection and improve the chances for competition between insurers to 
lead to higher cost-effectiveness, but to avoid distortions some aspects of the 
design will have to be corrected before the system is introduced in 2009.  
The largest part of the system’s costs will continue to be financed by labour-
income dependent contributions, protecting lower income earners, while the price 
signal will come from a surcharge that those insurers that otherwise cannot cover 
their costs will have to levy on their members. (…) Moreover, the associated 
redistribution will be financed within surcharging insurers’ memberships, putting 
insurers with a large share of low-income earners at a competitive disadvantage, 
because they will have to levy higher surcharges on higher income members. (…) 
The current segmentation of the health insurance system will be maintained, 
raising equity and efficiency concerns. Private health insurance members are both 
healthier and wealthier on average than social insurance members and 
segmentation leads to less efficient risk pooling, leading to higher social 
contributions and ultimately to lower employment and economic growth with 
negative effects for society at large. In addition, it raises equity concerns to 
exempt private health insurance members from contributing to the financing of the 
various re-distributive tasks performed within the social insurance system, such as 
free co-insurance of family members without own income. Private health insurers 
should be included in the new financing system. 
 
 
 
In Germany the options available for health insurance while living in Germany are: 
 Government-regulated public health insurance system; 
 Private health insurance from a German or international insurance 
company; 
 combination of the two. 
 
Government Health System 
Most German residents are members of the government health system 
(Gesetzliche Krankenversicherung or GKV). If the gross annual salary is below 
48,150 Euros per year or 4,013 Euros per month, membership in the GKV is 
mandatory. The total cost of government health insurance is currently approx. 
15% of gross salary up to a maximum monthly income of 3,600 Euros. If a person 
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earns more than this amount the insurance premium remains constant. The 
employer will normally pay slightly less than half of the monthly premium. 
GKV benefits include in-patient (hospital) care as a ward patient with doctor on 
duty at your nearest hospital, out-patient care with registered doctors 
(Kassenärzte) and basic dental care. The non-working dependents resident at 
the emplyoee address in Germany is included in the insurance with no 
additional cost. 
Members of the GKV will join one of the 250 "Krankenkassen" in Germany (non-
profit associations administrating the government health scheme). The health 
insurance funds adhere to established government regulations on what they 
offer. 
The employee and their dependents are automatically enrolled in the 
government long-term nursing care scheme. This presently costs 1.95% of the 
gross salary (a maximum of approx. 80 Euros per month) of which the employer 
pays half. 
For those seeking to upgrade their medical coverage, for instance the right to 
consult a private doctor, to homeopathic remedies, a private room in hospital 
and higher dental reimbursements, supplemental insurance coverage is 
available which can top up the government system benefits. 
 
Private Health Insurance 
It is possible to opt for private health insurance (Private Krankenversicherung or 
PKV) instead of joining the government health plan if the gross annual salary is 
presently more than 48,150 Euros and has been more than 47,700 Euros per year 
for each of the past three years. If not, automatically the person is registered 
as a voluntary member of the government system and will not be able to change 
to a private insurance plan until the person have been a member of the 
government system for up to 3 years. 
Generally, private health plans cover a wide choice of medical and dental 
treatment and provide broad geographical coverage. Private patients generate 
higher earnings for medical professionals and will usually be treated by senior 
doctors.  
The cost of full medical insurance is based on the benefits chosen, as well as on 
the age, gender and any pre-existing conditions of the insured. The monthly 
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cost of the private insurance czn is reduced by agreeing to a deductible. Private 
insurance premiums are based on the insured individual and do not 
automatically include the dependents who will be covered under the policy at 
their own individual rates.  
By purchasing a private medical insurance plan from a German health insurance 
company that provides a certificate recognized by the German government 
(Arbeitgeberbescheinigung) it has the advantage of the same employer subsidies 
as a government plan member. 
Everyone, whether state or privately insured, must pay into the government 
long-term nursing care scheme. 
The principal characteristics of the Private Health Insurance are: 
 Whole life guarantee: while the premiums are being paid by the 
policyholder, the insurance company cannot cancel the contract or 
reduce the coverages (“once private, ever private”); 
 Benefits/Coverages similar to the public system; 
 Level premiums: As the actuarial assumptions, the total future 
benefits must be equal to the total future premiums, having into 
consideration a certain expected income rate. The premiums can be 
corrected on base in the medical inflation costs. 
 
There are several specificities of this insurance, where can be highlighted 
the following: 
- Application of an extra premium (about 10%) until the age of 60 years 
in orders to finantiate the high claims ratio that occurs in the higher 
ages. 
- Existence of profit sharing clauses that distribute at least 80% of the 
balance to apply to the reinforcement of the technical account with 
insured persons with higher ages. 
 
 
The transfers between public and private have very specific rules, once the 
alternative system has a whole life guarantee. If one person leaves the public 
system and get into the PHIS, that person can only get back to the public 
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system if their income is less than the minimum amount 40.500€/year or if the 
person has less than 55 years old. 
 
 
1.2.2 PUBLIC VS PRIVATE HEALTH MANAGEMENT 
 
In Germany, public funds financed 79% of the total expenditure: The general 
government paid 10% and social security funds financed 69% of the total health 
expenditure in 2001. Private households paid 11% of the total expenditure. 28% of 
the expenditure of the private households was spent on pharmaceuticals, of which 
18% was on over-the-counter medicines and 10% as co-payments for goods and 
services such as pharmaceuticals. 20. 8% of the total expenditure was paid by 
private insurance enterprises, 2% by nonprofits organisations and 1% by 
corporations (for occupational health care). The next figure illustrates the 
exposed. 
 
 
Figure 1.9 – Health expenditure by financing agent (Total health 
expenditure=100), Germany 2001 
 
 
 
Source: OECD Health Technical Pappers no.4, Sha-Based Health Accounts in thirteen OECD countries, 
Country Studies: Germany National Health Accounts 2001, Natalie Zifonun 
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1.3 FRENCH HEALTH SYSTEM 
 
1.3.1 HEALTH CARE CONTEX 
 
 
According to OECD Health Data 2008, the health spending accounted for 11,1% of 
GDP in France in 2006, more than 2 percentage points higher than the average of 
8.9% in OECD countries. 
Only the United States (15.3%) and Switzerland (11.3%) allocated more of their GDP 
to health than France in 2006. 
On the other hand, France ranks over the half of the OECD countries in health 
spending per capita, with spending of 3,449 USD per person in 2006 (adjusted for 
purchasing power parity). The OECD average in 2006 was 2,824 USD per capita. 
The public financing represents the principal source of health financing expenses 
beneath the other OECD countries, with the exception of United States and Mexico.  
 
In France, 79,7% of health spending was funded by public sources in 2006, above 
the average of 73% in OECD countries. 
In 2006, life expectancy at birth for the whole population in France stand has 
increased more than ten years between 1960 and 2006, which is close to the data 
of half of the OECD countries. 
 
 
In France the health care system is compulsory and covers the entire French 
population. The French citizens can acced to the public health service through the 
payment of fees. 
All population have to be inscript in the Social Security in the “compulsory 
regime”. This institution is responsible for part of the health expenses, and 
reimburses part of the conventioned tariff. This regime reimburses a percentage of 
that tariff according to the nature of the medical act. The taxes of the Social 
Security change for the different social security regimes. 
The compulsory regime leaves a tax charge to the citizen, which is the difference 
between the conventioned tariff and the percentage assumed by the compulsory 
regime. There are some health conditions in which there in no tax charge. The type 
of the regime in which each citizen is inscript depends on the personal or 
professional situation.  
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There are five kinds of compulsory regimes of the Social Security: 
 
 Global regime for the workers hired; it is managed by the Caisse nationale 
d'assurance maladie (Cnam) and for Caisses primaires d'assurance maladie 
(Cpam). There is a special regime for the employees who work in Alsace-
Moselle and for some kind of employees namely the civil servants and 
military servants. 
 Compulsory regime for the independent employees; it is reserved to the 
artisans, industry servants and liberal professionals. 
 Agricultural regime (Amexa); for the agricultural workers and it is managed 
by the Mutualité Sociale Agricole (MSA). 
 Students regime; it is compulsatory for all the students with an age over 20 
years old and who study in a superior establishment recognized by the 
French state. 
 Resident regime; Funded in the year 2000, it covers all the persons that live 
in France and do not benefit from any other social regime. 
 
 
Private Health Insurance 
The private health insurance is an additional insurance to french compulsory 
regimes with the exception of incapacity and disability covers. 
 
Private health insurances can have a whole life guarantee, named “Garantie 
Viagère”, with an eliminate period of 2 years that can be extend until 3 years. 
 
In the case of group policies with compulsory adhesion, the complementary insurers 
(Insurances companies or Mutuals), cannot refuse the acceptance of the 
responsibility of pre-existing diseases. There are no elimination periods in the 
compulsory group policies. 
 
In the individual or group policies with optional adhesion, the contracted guaranty 
is for lifetime since the date of adhesion. Since the contract is done, the insured 
person has the right to maintain the guaranties and the insurer cannot put an end 
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to the contract, but can chance the tariff according to the tariff category but not 
according to the person health status. 
However, there is a clause in which the insurer is allow to examine during 2 years 
the claims costs of the insured person. If during that period the costs are 
excessively high, the insurer can decide to cancel the contract. 
 
 
 
1.3.2 PUBLIC VS PRIVATE HEALTH MANAGEMENT 
 
 
Figure 1.10 - Financing structure of health expenses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: INE, Contas nacionais da Saúde de 2001 
 
 
In France, Social Security financed 75,5% of the total expenditure in 2001. Private 
households and Mutual are the following concerning the financing amount with 
11,1% and 7,4% respectively.  Insurance companies have only financed 2,8% of total 
expenditure. 
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1.4 COMPARISON OF HEALTH SYSTEMS 
 
This section aims to compare the Portuguese, Germany and French health systems 
concerning the main figures related to their health systems.  
 
Table 1.15 – Expenditure on Health, comparison countries 
YEAR 2006 Portugal Germany France 
Total expenditure on health % Gross Domestic Product 10,2 10,6 11,1 
Public expenditure on health % total expenditure on 
health, TEH 
70,6 76,9 79,7 
Total expenditure on health /capita, US$ purchasing 
power parity 
2 120 3 371 3 449 
Source:OECD Health Data 2008 – Version: June 2008 
 
 
As the previous tables illustrates, France is the country with higher expenditure on 
health as a percentage of the GPD. Germany and Portugal have almost the same 
volume of health expenditure. 
Regarding the total health expense per capita, Portugal presents a lower spend, 
which is a reflect of being a less rich country. 
 
 
Figure 1.11- Health expenditure as share of GDP, OECD countries, 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: OCDE Health Date 2008, June 2008 
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In an overview between all OECD countries, the three countries in analysis are far 
above the OECD average concerning health expenditure as share of GDP, which is 
8.9. 
 
Figure 1.12- Health expenditure per capita, OECD countries, 2006 (USD PPP) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
         Source: OCDE Health Date 2008, June 2008 
 
 
The health expenditure per capita differs from Portugal to Germany and France. 
Portuguese amount of health expenditure per capita is 2.120 USD far below the 
OECD average of 2.821 USD, Germany with 3.371 USD and France with 3.449 USD. 
 
 
Figure 1.13 – Total Health expense in GDP and total expense per capita, 
(US$PPP), 2004 
 
 
Legend: AL-Germany; AU-Austria; DK—Denmark; ES-Spain; FI-Finland; FR-France; GR-Greece; HO-Netherland; IR-
Irland; IT-Italy; LX-Luxemburg; PT-Portugal; RU-United Kingdom; SU-Sweden 
Source: OECD Health Data 2006, October 2006 
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Nevertheless the data of the previous figure refers to the year 2004, the 
performance of the expenses is still similar in the year 2006. The figure above 
shows the relation between the total health expenses in GDP and the health 
expenses per capita. The circle on the bottom right figure, contains the three 
countries in study, it could be assumed as a cluster that joins the countries with 
higher expenses as share of GDP, although Portugal has a lower per capital amount 
of expenses.   
 
 
Figure 1.14 – Public and Private health expenditure - 2006, comparison 
countries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: OECD Health data 2006, October 2006 
 
 
The previous figure, illustrates the share in the public and private health expenses. 
Portugal has a public participation in health, slightly below the average of the EU 
(15 countries) with 73%. This, means that Portugal spend more than the average of 
EU countries concerning the wealth procuded in the country. Germany and France 
have a higher expenditure concerning the public expenses than the average of EU 
countries. 
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2. AN APPROACH TO THE WHOLE LIFE HEALTH INSURANCE  
 
Health is a vital condition for everyone. The health insurance is a good help in the 
preservation of a healthier status. Once the concerns and demands in this matter 
are growing and the population is getting older, the whole life health insurance is 
something that will cover up the existent market insurance gap and the citizens 
needs. 
The ISP, while a control authority has established as priority, the development of 
the basic regulation about the lifetime health insurance exploration. The insurance 
market has already some health insurances that cover the risk for higher ages. 
However, in order to contribute to the development of lifetime health covers, the 
ISP finds suitable the regulation of some technical aspects to adjust prudent rules. 
(III Fórum do Sector Segurador e de Fundos de Pensões,“O Sector e o Sistema de 
Segurança Social – Perspectivas para 2008”, Lisboa, 4 de Março de 2008) 
 
In this section, it is purposed an approach to a methodology for the calculation of 
the level premiums to the whole life health insurance. 
To this intent, it was used the data of a health insurance Company implemented in 
the Portuguese market. 
  
2.1 OVERVIEW 
  
2.1.1 INSURANCE DESCRIPTION 
 
The whole life health insurance is not yet into operation in Portugal with levelled 
premiums.  
The president of the ISP, Fernando Dias Nogueira, declared to the Finantial Agency 
(April 2008) that in the health domain, the major concern and priority was the 
implementation of the whole life health insurance for the year of 2008. 
 
 
According to the Quarterly Bulletim of PAI, 2005, the real whole life health 
insurance, with exact rules about the future evolution of the premiums and the 
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guaranteed coverages are explored in a scarce number of markets. The whole life 
health insurance has in general high costs.  
This kind of insurance is always related to opting out models or models that 
substitute the public health care systems. They are based on a funding principle 
that guarantee the equivalence of the premiums and the claims expected for the 
duration of the contact and their exploration is viabilited by the regimes of exempt 
contributions for the Social Security and by incentives or rules that assure a 
balanced mutuality of risks. 
 
Regarding the contract conditions, there are relevant clauses that differ from a 
standard health insurance and have to be considered. 
 
 Insurers restrains concerning the cancellation or coverages changes: It is a 
basic requisite for a whole life health insurance that once the contract is 
settled, the insurer cannot cancel or changes any coverage (due to a change in 
the health status of the policyholder or an increase in of the risk) without 
according it with the policyholder. Only the non-payment of the premium or 
any kind of fraud is acceptable. 
 Policyholder’s freedom concerning the cancellation or coverages changes: on 
the opposite of the insurer, the policyholder has the liberty to cancel the 
insurance contract under some specific rules (e.g. only at the end of the 
annuity) and penalties expressed in the General Conditions (e.g. charge for 
administrative costs). The change in the coverages has to be with common 
agreement. 
 Pre-definition of the criterion of future premiums adjustment: The rules 
considering the adjustment of the annual premium, the annual limits, the 
deductibles or co-payments must be settled in the moment of the contract 
celebration. Most of the times these values are rated with the inflation of the 
health sector, the evolution of the general cost in health and other 
macroeconomic figures. Each insurer before the contract celebration will 
define these conditions. 
 
The technical basis for the whole life health insurance are supported by the 
funding principle, which will allow the leveling of the annual premiums along the 
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entire contract, based on the principle of equivalence between the premiums and 
the expected future claims, pondered by income rates, inflation, mortality indexes 
and other variables. 
 
2.1.2. INSURANCE PREMIUM  
 
In order to attain the guaranties for a whole life health insurance, once the 
contract is a long-term investment, the premiums rated must be levelled. 
 
Most insurances have a rising premium policy, where the premiums increase with 
age. This kind of premium is named stepped premium. 
In a level premiums policy, there is a fixed premium for the life of the policy, 
which means that the insurer quotes a premium that will remain the same (in the 
majority of cases) from year to year for the same level of coverages. 
 
The level premium paid on this type of policy will be higher at the beginning of the 
contract but lower towards the end of its life as compared to a common policies 
that have rising premium rates (stepped premiums).  
 
 
Figure 2.1 – Stepped versus Leveled Premiums  
 
 
 
 
 
 
 
 
 
 
 
Source: Author’s calculation 
 
To further illustrate the savings that could potentially make over a lifetime, the 
previous figure shows the point in time where the cost of the level premium starts 
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to become cheaper than the cost of stepped premiums. This case assumes a male 
policyholder aged 30 years old, with a health insurance with the coverages: In 
Patient, Out Patient and Dental.  For this person, until the age of 50 he would pay 
a higher premium, but after the 50, the leveled premium would be less than the 
stepped premiums. Therefore, while initially level premiums may be more 
expensive, over the long term, they are a far cheaper.  
 
The premium is normally more than the actual claims cost of protection during the 
earlier years of the policy and less than the actual cost in the later years. 
The building of a reserve is a natural result of level premiums. The payment in the 
early years, together with the interest that is to be earned, serves to balance out 
the underpayment of the later years.  
The advantages related to the contract of a level premium cover are: 
 
 
 No Premium increase 
Knowing that your premiums will not increase with age allows you to budget 
more easily for the future. The big advantage of a level premium is that you 
know in advance what the premiums will be and don’t find you can’t afford the 
cover when you need it most. 
 
 Long –term Affordability 
Although a level premium option will cost you more initially, the total cost over 
the life of the policy is considerably less. This gives you certainty, and long 
term affordability. 
 
 Simplicity 
With a level premium policy you are required to undergo one health check only, 
at the policy’s inception. 
  
This kind of insurance has a whole life guarantee, which means that the contracted 
conditions will be maintained until the end of life of the insured person unless in 
the cases mentioned in the bullet 2.1.1. 
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2.2 PREMIUMS CALCULATION METHOD 
 
The next information will express the method under which this study was realised. 
The characteristics of the universe in study, the procedures applied to the 
extraction of the data and finally the calculation method for level premiums is 
described. 
 
 
2.2.1 UNIVERSE OF THE SAMPLE 
 
The data used in this calculation is from a health insurance Company with an 
historical data of ten years, which gives good statistics regarding the Portuguese 
health insurance market.  
The universe in study corresponds to 15,8% of the total Portuguese health insured 
persons, and 2,5% of the Portuguese resident population. The data chosen for the 
calculation is only from Managed Care domain, which corresponds to 79% of the 
total portfolio of insurance Company mentioned. 
 
The records concern to a universe of 269.434 insured persons with ages between 
zero and hundred years, being 48% Males and 52% Females. 
 
 
2.2.2 INSTRUMENT AND PROCEDURES FOR THE SAMPLE COLLECTION 
 
The instrument for the extraction of the data was the internal application software 
used in the insurance Company in parallel with the Access tool. The information 
was extracted from the central database of the Company therefore the confidence 
is entire.  
There were made some queries to database in order to collet the desired 
information, Claims and Number of Insured Persons for the ten years of data 
available. Some filters were made in order to get only the Managed Care portfolio 
universe. 
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2.2.3 DATA ANALYSIS 
 
For the calculation of the premiums, two fundamental factors were considered: 
technical interest rate and costs per insured person. 
 
The premiums were calculated for each insured person on the basis of the risks 
envolved and according to the principle of equivalence. Which means that for the 
entire period insured, the total future premiums must be equivalent to the total 
future expected benefits.   
 
The premiums calculations were made to the individual health risk, which was 
determined by four factors as: 
 
I. Claim Cost per Insured Person; 
II. Medical Inflation Rate; 
III. Technical Interest Rate; 
IV. Mortality Table; 
 
 
I.  Claim Cost per Insured Person 
 
The claim cost per insured person is the basis of the premium calculation. With 
the historical data of the insurer it is possible to obtain an adequate amount of 
statistics in order to build a tariff. 
To improve the credibility level of the data used, the records were divided into 
age groups (five to five years).  
 
To determine the Cost for each year, the variables used were: 
- Claims paid by year, age group, gender and coverage;  
- Number of insured persons by year, age group, gender and coverage; 
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If Syx is the total amount of Claims Paid for an age group x in the year y, Lyx the 
total Insured Persons in the age group x in the year y at risk, then, the claims 
per age group Kyx is:  
 
(1)     
x
x
x
Ly
Sy
Ky =           
 
In order to compare the claims per age group of the different years, all the 
years were updated with the medical inflation rate to the current year. Thus, as 
described in the previous bullet, considering imir, the medical inflation rate, for 
the year y the updated claims per age group for 2008 is: 
 
(2)    )2008()1( ymirx iKy
−
+×  
 
 
The last very recent years of the claims paid data do not have all the total 
amount of claims reported yet. Which means that the year is not yet closed 
concerning the claims to be paid by the insurance company. This might be due 
to some delays in the management process of the claims, any constrain in the 
acceptance of the claims or the simple delay on the reporting of the claim 
occurrence. To make sure that the total amount of claims are considered in the 
calculation, it is necessary to estimate/project paid claims amount that remain 
to be reported later than.  
 
Tail factor is a coefficient that determines an estimation of the claims that will 
still occur and/or be presented for payment.  
Tail factors are used to estimate the additional development that will occur 
after the eldest maturity in a given loss development triangle, or after the 
eldest credible link ratio. (Ryan, 2005)  
 
Tail factor takes losses from experience in the triangles to their ultimate value. 
The compute for the Tail Factor involved all the historical data of the 
development for all years prior to 2007, and compare this aggregate 
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development amount to policy year 1998 losses evaluated at the end of the 
corresponding calendar year (2007 development/1998 losses evaluated at end of 
2007, etc.).  These quotients were converted into 9th report to ultimate link 
factors, and the average of these, after an adjustment for growth, is the tail 
factor.  
 
Let Tfy represent the tail factor to the year y. 
 
Finally, with the tail factor parameter calculated for each year, the Claim cost 
per age group x for the year y (Cyx), comes: 
 
(3)    y
y
mirxx TfiKyCy ×+×=
− )2008()1(  
 
The result of this equation is a claim profile for that age group. 
 
 
From the data available, it was selected the most recent figures since the year 
2002. For each year, and for the different age groups, it was adjusted a 
function to each claim profiles in order to combine them and get a unique claim 
profile for each coverage.  The adjustment of that function has varied from 
coverage to coverage and from segments of age groups. The majority of the 
cases, the adjustment made was with a polynomial function. 
 
As the claims adjusted functions were divided by age groups, with the 
Interpolation methodology, it was calculated the Claim cost per Insured Person 
for each age. 
 
Let the Claim cost per insured person be represented by Ch. 
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II. Medical Inflation Rate 
 
“The driver of the insurance premium or funding level is the claims that the 
insurers believes will be incurred over the approaching policy year. (…) Making 
projections about the level of the future experience requires the extrapolation 
of trends from the past into the future, and, hence, the level of medical 
inflation used in a pricing exercise becomes a central assumption.” (Mercer’s 
point of view: Medical Inflation, July 2008) 
Medical inflation is a global phenomenon. Whether in private or through public 
system, costs are raising with demand and complexity. 
The Medical Inflation is due to the increase of medical costs as well as the 
increase of the medical technology. Upward pressures on medical costs include 
a boom in the construction of health care facilities and hospitals. 
Medical inflation is normally higher than the general rate of inflation. 
For example, the costs in U.S. rose 8% in 2007 and will go up another 11% in 
2008. In Canada, costs rose 11,5% in 2007 and will go up to 12% in 2008. In UK’s 
costs there were up to 8% in 2007 and will maintain for 2008. France saw 
inflation of 6,6% in 2007 and will hit 7,3% this year. (Blankenhorm, 2008)  
 
This study has considered the medical inflation between 2% and 3,5%. With 
different medical rates, it was calculated the level premium in order to attain a 
sensitivity analysis to this parameter. 
 
Let The Medical Inflation Rate be denoted by imir. 
 
 
 
III.  Technical Interest Rate 
 
The Technical Interest Rate is very important in the premium calculation. 
Technical Interest Rate is the factor that updates the costs and the premiums 
to a determined date. The interest rate is normally expressed as a percentage 
over the period of one year. 
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The actual interest rate is 2,322%5.  
In this study the interest rates used were between the values 2% and 3,5%. 
With different rates, it was made different scenarios in order to attain a 
sensitivity analysis. 
 
Let denote the interest rate of the paid claims as ip 
And the interest rate of the received premiums as ir . 
 
 
IV.  Mortality Table 
 
In order to tariff the level premiums, and to ensure the solvency of the insurer 
through adequate reserves, projections must be developed of future insured 
events, namely death. This is done studding the incidence and severity of the 
events in the recent past, developing expectations about how the drivers of 
these past events will change over time. These events are usually in the form 
of tables of percentages indicating the number of death events that will occur 
in a population. The Mortality table shows, for a person at each age, what is 
probability that they die before their next birthday. The mortality tables 
provide the rates of mortality or death. 
 
Considering the notation of qx as the probability of death for a person with 
age x, then, 1- qx = px will be the probability of survive for that person. 
Therefore, let h-xpx be the probability of a person with age x survive to age (h-
x)+x = h.  
 
 
 
With all the four factors that contribute to the calculation of the premium as the 
medical inflation rate, the claim cost per insured person, the technical interest 
rate and the mortality table defined; the level premium can be planned. 
 
                                                 
5 EONIA/day,11 December, European Central Bank e REUTERS 
  66
 The Benefit paid by the insurer occurs every time the insured person requires 
medical assistance that is covered by the insurance policy. 
The Claims that the insurer expects to pay for an insured person with age y is:  
 
(4)    
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With: 
Ch = Claim cost per insured person/ year h; 
h-ypy = probability of a person with age y survive to age h; 
imir = Medical Inflation Rate; 
ip= interest rate associated to paid claims. 
 
 The policyholder pays the Premium continuously, and it must be paid in an 
annual or monthly basis. As a result, the amount that the insurer expects to 
receive from the policyholder related to the total amount of premiums of an 
insured person with age y, is given by the following expression: 
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With: 
Py = level premium at entry age y; 
h-ypy = probability of a person with age y survive to age h; 
ir= interest rate associated to received premiums. 
 
 
Regarding the age and gender of the insured person, the level premium for an 
insured person with age y, can be obtained through the Principle of Equivalence of 
level premiums by making corresponding the expressions (4) and (5),  
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Consequently, the level premium for an insured person with age y, is the result of 
the following equation: 
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Where, 
Ch = Claim cost per insured person/ year h; 
h-ypy = probability of a person with age y survive to age h; 
imir = Medical Inflation Rate; 
ip= interest rate associated to paid claims; 
Py = level premium at entry age y; 
ir= interest rate associated to received premiums. 
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3.  RESULTS 
 
In this chapter, the results of the calculations made according to the formulas 
presented in the previous chapter, will be described and illustrated. In the first 
part of this chapter, the presentation will be related to claim costs. The second 
part of this section will focus in the level premiums.  
 
3.1 CLAIM COSTS 
 
The outcomes of the formulas presented previously, will be illustrated with an 
example for the In-patient and Out-patient coverages. 
Regarding the calculation of the claim costs, the result of the formula (3) is, for 
claims profile Cyx as the next figure shows. 
 
Figure 3.1.1 – Claim costs per age Group for the coverage Out-Patient 
(male)  
 
 
 
 
 
 
 
 
 
Source: Author’s calculations 
 
It is possible to verify that for the first years of life, the claim costs have a 
decreasing tendency until the age group 20-25 years old. From these ages forward, 
the claims costs increase with the age until the 80’s. The claims profile is very 
regular along the years until the 70 years old. The number of insured people over 
the age of 70 years represents only 3% of the total portfolio for each year (these 3% 
correspond only to the group policies once the individual had a limit age of 
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permanence in the insurance). This fact explains the differences demonstrated in 
the profiles for ages above 70, once there is not enough data to get a complete 
credibility level. However it is likely that the number of insured persons with ages 
over 70 will increase in the private insurances once the insurance companies are 
beginning to abolish the limit age of permanence.  
The consequence of the formula (3), after being made the adjustment of a function 
(polynomial or other), resulted in:  
 
Figure 3.1.2 – Adjusted Claim costs per age Group for the coverage Out-
Patient (male) 
 
 
 
 
 
 
 
 
 
Source: Author’s calculations 
 
As the older ages are a risky segment, in this study, for these critical groups it was 
made an adjustment to the claim costs by levelling them by the higher expenses.  
 
Figure 3.1.3 – Comparison of Adjusted Claim cost per age group for the 
coverage for Out-Patient, males and females 
 
 
 
 
 
 
 
 
 
 
 
Source: Author’s calculations  
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In the Out-Patient coverage, the claim costs profiles for males and females are 
quite different. This difference is sharped between the 20 and 40 years and the 
cause of this disparity is due to the claim costs related with pregnancy in females. 
 
Figure 3.1.4 –Comparison of Adjusted Cost profile per age group for the 
coverage of In-Patient, males and females 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Source: Author’s Calculations  
 
 
The figure above, illustrates the In-Patient claim costs for males and females. The 
profiles are fairly similar until the age of 70 years old, after this age, the male’s 
claim costs present a significant increase. The historical data of this insurance 
Company has always presented higher claim costs for males in this coverage and in 
this segment. A justification for this increase is the fact that males do not have a 
continuous medical monitoring when they are young, as the profile of Out-Patient 
demonstrates. As a consequence, in the end of their lives, males have a tendency 
to be less healthy and need more In-Patient care. 
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3.2 PREMIUMS 
 
The formulas for the premiums calculations were presented in the bullet 2.2.3. The 
results illustrated in this section do not have into consideration any limit, co-
payment or deducts and they are considering 100% of reimbursement. These 
premiums are pure risk premiums without commissions or fees. 
 
For the following assumptions,  
 Mortality table: TV 73/77 
 ip = 2% 
 ir=3% 
 imir=3,5% 
 
The calculation result of level premium for the males, for each coverage and for 
the sum of the all coverages is illustrated in the figure below. 
 
Figure 3.1.5 – Pure Level Premium to whole life health insurance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Author’s Calculations 
 
 
For each age of entry the level premium is draw in the figure on top. The previous 
chart should be read as follows, each coloured line represents the level premium 
for one coverage, and the dark red line is the levelled premium for the five 
coverages as considered. 
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A person aged 30 years old, who wants to apply for the whole life health insurance, 
must pay a level premium of P in the year of subscription and for the rest of his 
life. 
An insured person with the age 30 years old will pay a level premium higher than 
an older insured person. As the claim costs increases with age, a younger person 
will start paying a level premium higher than his actual costs in order to constitute 
a provision for the moment were the premium is not enough to cover his costs. 
 
The result of one scenario of level premiums with the same limits and coverages of 
a standard tariff of a common health insurance were compared and the figure 
below illustrates the comparison. 
 
Figure 3.1.6 –comparison of the level premiums and the standard tariff 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Author’s calculation, health insurance standard tariff 
 
This figure illustrates the premium that for any entry age, the person will pay at 
the present moment. The difference is that, with the standard health insurance the 
premium will develop as the blue line along the years. With the level premium, the 
person starts and ends the insurance with the same premium amount. The dark red 
line is not the evolution of the level premiums but the levelled premium for each 
entry age.  
 
The whole life health Insurance with level premiums is still an expensive insurance 
when people think in a short term, but if the perspective is to guarantee the future 
health, it is a good investment. 
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3.3 PREMIUM ANALYSIS  
 
In this section, it will be explained some analysis made to the result of the 
premiums obtained in bullet 3.2. The purpose of this analysis was to get sensitivity 
to the factors that contribute to the premium calculation in order to know how is it 
possible to manage the factors to get a lower premium, or which factors leads to 
higher premiums also. 
 
As it was mentioned previously, the calculation of the premium was determined by 
several factors, these factors are related to the market conditions and to medical 
development, so they can vary with external conditions of the insurer and return 
an impact in the premium. 
 
The medical inflation rate, the interest rate of the paid claims and the interest 
rate of the received premiums are variables that influence the level premium.   
In order to get a thought of how each of these technical factors manipulates the 
premiums, it was made a sensitivity analysis and the following results were 
obtained: 
 
Table 3.1 - Effect in the premium by the change in the technical factors 
Increase in the Factor Effect in the Level Premium 
ip Decrease 
ir Increase 
imir Increase 
 
The performance of the increase of the rates has different effects in the level 
premium. An increase of the interest rate of the paid claims (ip) leads to a 
decrease of the premium, for the other two rates, the opposite occurs. However, 
when increasing the same amount in the interest rate of the received premiums (ir) 
and the medical inflation rate (imir), the level premium is higher with the increase 
of the medical inflation rate. 
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Mortality table: TV 73/77
scenario ip ir imir scenario ip ir imir
1 2,0% 3,0% 3,5% 15 2,0% 2,0% 3,0%
2 3,0% 3,0% 3,5% 16 2,0% 3,0% 3,0%
3 3,5% 3,0% 3,5% 17 3,0% 3,0% 3,0%
4 3,5% 3,0% 3,0% 18 3,0% 2,0% 2,0%
5 3,5% 3,0% 2,0% 19 3,0% 3,0% 2,0%
6 3,5% 2,0% 2,0% 20 3,0% 3,5% 3,5%
7 3,0% 2,0% 3,0% 21 3,5% 2,0% 3,0%
8 2,0% 2,0% 3,5% 22 3,5% 3,5% 3,0%
9 2,0% 3,5% 3,5% 23 3,5% 2,0% 3,5%
10 3,5% 3,5% 2,0% 24 3,5% 3,5% 3,5%
11 3,0% 3,5% 3,0% 25 3,0% 2,0% 3,5%
12 2,0% 2,0% 2,0% 26 3,0% 3,5% 2,0%
13 2,0% 3,0% 2,0% 27 2,0% 3,5% 3,0%
14 2,0% 3,5% 2,0%
For the same mortality table, and for three different rate percentages (2%, 3% and 
3,5%), it was made all the combinations for ip, ir and imir to know how the different 
factors interfere together in the premium. 
The table below present the total combinations of the rates; furthermore, the next 
figure shows graphically the level premiums as a result of the different scenarios. 
 
Table 3.2 – Scenarios for different rates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.7 –Total Level premium for different rates  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Author’s calculation 
 
 
As the figure illustrates, the impact of the different rates is significant. The best 
scenario - 6 (with the lower level premiums) is the one with ip=3,5%, ir=2,0% and 
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imir=2,0%. The worse scenario - 9 (with the higher level premiums) is the one with 
ip=2,0%, ir=3,5% and imir=3,5%. 
 
In order to find out which of the previous scenarios were similar, it was made a 
cluster analysis. “Cluster analysis is more primitive technique in that no 
assumptions are made concerning the number of groups or the group structure. 
Grouping is done on the basis of similarities or distances.” (Johnson R. A. and 
Wichern D. W., 1992)  
The procedure adopted in order to group, was the distance. For all the 27 
scenarios, it was calculated the squared Euclidian distance between every two 
scenarios. As the following example demonstrates; 
 
Let scenario 1 be denoted by C1 and scenario 2 by C2, then C1=[c10, c11, c12, 
…c1105]’ where c10 represents the level premium for the age 0 and with C2 =[c20, 
c21, c22, …c2105]’, the Euclian distance between both scenarios is: 
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Consequently, it was calculated the squared distance between scenarios as: 
                                            ∑
=
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jj cc   
 
These distances were computed in R program (version R 2.7.1) in order to verify 
graphically which scenario was related with another. The three methods were 
chosen for the display of the dendogram: the single linkage, the complete linkage 
and the average linkage for the distances between 27 scenarios.  
 
The inputs for the Single Linkage algorithm were the distances between pairs of 
scenarios. In this method, groups are formed from the individual entities by 
merging nearest neighbours, where the term nearest neighbour connotes smallest 
distance.  Initially, it is found the smallest distance in D={dik} and merge the 
corresponding objects to get the cluster. 
Comentário [BP1]:  
  76
The Complete Linkage clustering proceeds in much the same manner as single 
linkage, with one important exception. At each stage, the distance between 
clusters is determined by the distance between the two elements, one from each 
cluster, that are most distance. Thus complete linkage ensures that all items in a 
cluster are within some maximum distance of each other.  
The average linkage treats the distance between two clusters as the average 
distance between all pairs of items where one member of a pair belongs to each 
cluster. 
 
As an example, the figure below illustrates the result of the complete linkage 
method. 
Figure 3.1.8 – Cluster Dendogram 
Source: Author’s calculation 
 
The dendogram shows the hierarchical clustering, the groupings and the distance 
levels at which they occur.  
It can be observed that some scenarios as (C5,C15,C2) , (C24,C11,C20) and (C6, 
C19, C21) cluster at first level. The scenario C17 remain by them self until an 
intermediate level, which means that for ip=3,0%, ir=3,0% and imir=3,0% the R 
program with the complete linkage method, consider that the premium achieved 
with this scenario is not clustering with any other premium in an immediate level. 
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4. CONCLUSION  
 
Health makes part of everybody’s life and is something that everyone is concerned 
about; therefore it is a current item to be discussed.  
 
In the first section of this document it was made a general overview about the 
Portuguese health system.  
The Portuguese health care system has three structures:  the public NHS, Special 
public and private insurance programmes and the private health insurance 
schemes. Considering the public organization, the NHS has been restructured in 
order to improve performance. The level of demand of the Portuguese citizens 
have increased, they want more and better access and quality to health care. 
Consequently, beside the improvements of the NHS, the private health sector 
activity continues to prosper in a fast way. At the present time, around 22% of the 
Portuguese population is covered by a private health insurance.  
 
The health insurance is a potential market to the insurers once, is not only the 
individual segment who looks for this product, but also employers who offer their 
employees this insurance as an extra-salary and also reap from fiscal incentives.  
The main conclusion of the first section is that Private health care providers mainly 
fulfil a supplementary role to the NHS rather than providing a global alternative to 
it. 
 
Besides the increase and diversity in the offer of private health insurances, there is 
still a gap in the available health insurance products. The insufficiency has to do 
with the age limit that some insurers establish or the absence of products to elder 
ages. Ageing is a consequence of many developed countries that poses series 
challenges for the health systems and for the economy generally. Particularly, in 
Portugal, ageing is also a reality, the ageing index has reached 113,6% in 2007. 
Therefore, a health Insurance with whole life guarantee is presently a priority 
demand.  
 
In the second part of this dissertation it was described the characteristics of the 
whole life health insurance and it was presented an approach to the level premium 
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calculation. The health insurance premium was calculated for each insured person 
on the basis of the risks involved and according to the principle of equivalence. 
This means that over the entire period insured the total of the premiums should 
match the total of benefits. 
For the calculation of level premiums, the following factors were of fundamental 
importance: claim cost per insured person, medical inflation rate, technical 
interest rate and the mortality table.  
 
The third section of this study presented the results achieved from the calculations 
of the level premiums. An important finding is that under uncertainly factors as 
interest rate and medical inflation rate the level premiums present considerable 
changes. The interest rate impacts in the level premium with an inverse 
proportion, the higher the interest rate, the lower the level premium. 
Another remark that can be taken from the results is that the level premiums for 
the whole life health insurance can be expensive when one thinks in a short term, 
but satisfactory regarding the long-term period.  
 
This work suggests several promising areas of future research.  
First, the data used in this study, had detailed health information but limited in 
terms of statistics for ages over 70 years old. Thus calculations may be more 
accurate if new data source is available. 
Second, the analysis of the level premiums has been limited to the calculation of 
the premium itself without taking into account some other important factors as the 
lapsation of the insured persons. It would be useful to extend the analysis with 
more sensitivity factors as lapsation and also consider the premium adjustment as a 
repricing when there are changes in the technical basis. 
Ultimately, the level premiums have the particularity of being higher than the 
claim costs of the insurer person for younger ages and lower in the older ages. This 
inverse proportion leads to a safety measure named reserves. The reserves were 
not mentioned in this study despite their huge importance. 
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Site Ministério da Saúde ( www.portaldasaude.pt) 
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APPENDIX 
 
Programming Code – R aplication 
 
#Leitura dos Dados 
Premios<-read.table("PremiosMasc.txt", header=TRUE, sep="\t",dec=".") 
 
op <- par(ask=TRUE) 
 
#Atribuição de nomes para as idades e para os cenários 
Idades<-array(names(Premios[,2:107])) 
Cenarios<-array(levels(Premios[,1])) 
 
#Tornar os valores mais pequenos  
Premios[,2:107]<-Premios[,2:107]/100 
 
#Tratamento e classificação dos cenários 
#Cálculo das matriz de distâncias euclideanas (distâncias entre cenários) 
euc<-dist(Premios[,2:107],method="euclidean") 
 
#Classificação dos ceários segundo três métodos 
 
#Método single clustering 
clusing<-hclust(euc,method="single") 
plot(clusing,labels=Cenarios,hang=-1) 
 
#Método complete clustering 
clucomp<-hclust(euc,method="complete") 
plot(clucomp,labels=Cenarios,hang=-1) 
 
#Método average clustering 
cluaver<-hclust(euc,method="average") 
plot(cluaver,labels=Cenarios,hang=-1) 
 
 
 
 
